SCHEMBL7832283

SCHEMBL7832283

CNS(=O)(=O)c1ccc(Br)cc1C1CCN(C(=O)OCc2ccccc2)CC1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.49
NPC1 O15118 2/20 0.49
RAB9A P51151 2/20 0.49
CYP2C19 P33261 1/20 0.47
MMP1 P03956 1/20 0.47
MMP2 P08253 1/20 0.47
MMP3 P08254 1/20 0.47
MMP7 P09237 1/20 0.47
MMP9 P14780 1/20 0.47
MMP8 P22894 1/20 0.47
HTT P42858 1/20 0.46
CCR8 P51685 2/20 0.46
JAK2 O60674 3/20 0.45
JAK1 P23458 3/20 0.45
TYK2 P29597 2/20 0.45
JAK3 P52333 2/20 0.45
GRIN2B Q13224 3/20 0.44
F13A1 P00488 2/20 0.44
TGM2 P21980 2/20 0.44
TGM1 P22735 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7675406 0.83 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL7834604 0.82 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9ACYP2C19MMP1
SCHEMBL7667749 0.80 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19MMP1
SCHEMBL7669575 0.80 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL25819235 0.79 SMN1; SMN2 (0.56) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL6608980 0.78 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19MMP1
SCHEMBL7672542 0.78 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19MMP1
SCHEMBL7828181 0.78 SMN1; SMN2 (0.53) SMN1; SMN2NPC1RAB9ACYP2C19MMP1
SCHEMBL19212122 0.76 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19HTT
SCHEMBL25329767 0.76 SMN1; SMN2 (0.64) SMN1; SMN2NPC1RAB9ACYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097137-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS AstraZeneca AB (SE) 2001-05-09 EP disclosed
WO-2000002859-A1 N-SUBSTITUTED NAPHTHALENE CARBOXAMIDES AS NEUROKININ-RECEPTOR ANTAGONISTS ASTRAZENECA AB (SE) 2000-01-20 WO disclosed